WHAT'S NEW

WuXi Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.

WuXi Expands in U.S. With Acquisition of XenoBiotic Laboratories, Inc.

We are very delighted to share with you that WuXi has acquired XenoBiotic Laboratories, Inc. (XBL), a contract research organization that provides...

Read more.

WuXi Corporate Venture Fund Participates  in Aldea Pharmaceuticals’ $24M Series B Financing

WuXi Corporate Venture Fund Participates in Aldea Pharmaceuticals’ $24M Series B Financing

Congratulation to our partner Aldea Pharmaceuticals on its closure of $24M Series B ...

Read more.

WuXi Facility Passes US FDA Inspection for Manufacture of API

WuXi Facility Passes US FDA Inspection for Manufacture of API

We are excited to announce that we have passed a second FDA inspection of our manufacturing facilities.  A manufacturing facility of WuXi's...

Read more.

WuXi’s Toxicology Facility in Suzhou Passes FDA Inspection

WuXi’s Toxicology Facility in Suzhou Passes FDA Inspection

The U.S. Food and Drug Administration (FDA) recently conducted a surveillance Good Laboratory Practice (GLP) inspection of WuXi's toxicology...

Read more.

WuXi Begins Operation of New High-Potency API Laboratory

WuXi Begins Operation of New High-Potency API Laboratory

WuXi's manufacturing subsidiary, Syn-The-All Pharmaceutical Co., Ltd (STA), has begun operation of a high-potency active...

Read more.

WuXi Selected as Top 20  Most Competitive Companies in Chinese Pharmaceutical Industry

WuXi Selected as Top 20 Most Competitive Companies in Chinese Pharmaceutical Industry

WuXi is selected as one of the top 20 public companies in competitive strength in the Chinese...

Read more.

IN CONVERSATIONS

The BioCentury China Healthcare Summit: The Bridge to Innovation

The BioCentury China Healthcare Summit: The Bridge to Innovation

The BioCentury China Healthcare Summit: The Bridge to Innovation is a strategic, VIP-only event that brings together decision makers to examine...

Read more.

"WuXi’s Mission Critical: Fostering Innovation by Servicing Biopharma" - An Interview by BioWorld

"WuXi’s Mission Critical: Fostering Innovation by Servicing Biopharma" - An Interview by BioWorld

Dr. Richard Soll, WuXi's Senior Vice President of International Discovery Service Unit, was recently...

Read more.

Dr. Steve Yang Interview: A Returnee's Perspective

Dr. Steve Yang Interview: A Returnee's Perspective

Our COO, Dr. Steve Yang, was featured in an executive interview: A Returnee's Perspective at the recent ChinaBio Partnering Forum in Suzhou...

Read more.

Thank you for your support in helping WuXi reach where we are today. We will continue with our goal - to serve you better with our integrated technology and capability platform.
 Office of Corporate Communications, WuXi AppTec

Web: www.wuxiapptec.com | Email: communications@wuxiapptec.com